HOSPIRA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA, and what generic alternatives to HOSPIRA drugs are available?
HOSPIRA has five hundred and seventeen approved drugs.
There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.
There are seventy patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and twenty-two supplementary protection certificates in sixteen countries.
Summary for HOSPIRA
| International Patents: | 70 |
| US Patents: | 9 |
| Tradenames: | 333 |
| Ingredients: | 210 |
| NDAs: | 517 |
| Patent Litigation for HOSPIRA: | See patent lawsuits for HOSPIRA |
| PTAB Cases with HOSPIRA as petitioner: | See PTAB cases with HOSPIRA as petitioner |
Drugs and US Patents for HOSPIRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira Inc | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065313-002 | Jan 23, 2006 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Hospira | LEVOFLOXACIN | levofloxacin | INJECTABLE;INJECTION | 078577-002 | Aug 12, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Hospira | TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | tobramycin sulfate | INJECTABLE;INJECTION | 063081-003 | Jul 31, 1990 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Hospira | PACLITAXEL | paclitaxel | INJECTABLE;INJECTION | 076233-001 | Aug 1, 2002 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Hospira | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 018053-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Hospira | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309-003 | Jan 26, 2007 | AP | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hospira | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | bupivacaine hydrochloride; epinephrine | INJECTABLE;INJECTION | 071166-001 | Jun 16, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HOSPIRA
Paragraph IV (Patent) Challenges for HOSPIRA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 4 mcg/mL, 50 mL and 100 mL vials | ➤ Subscribe | 2013-12-26 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
| ➤ Subscribe | Injection | 100 mcg/mL | ➤ Subscribe | 2009-04-08 |
| ➤ Subscribe | Injection | 4 mcg/mL, 20 mL vials | ➤ Subscribe | 2015-09-30 |
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
International Patents for HOSPIRA Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2806706 | ⤷ Subscribe |
| Denmark | 2648520 | ⤷ Subscribe |
| Spain | 2671749 | ⤷ Subscribe |
| South Korea | 20140096238 | ⤷ Subscribe |
| Singapore | 11201506113W | ⤷ Subscribe |
| Ecuador | SP13012569 | ⤷ Subscribe |
| South Korea | 101632103 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for HOSPIRA Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1948158 | 93075 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE SODIQUE SACUBITRIL VALSARTAN, C'EST-A-DIRE DE (3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3'-METHYL-2-(PENTANYOL(2''-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE) DE TRISODIUM HEMIPENTAHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123 |
| 1353647 | C01353647/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: AZTREONAMLYSIN; REGISTRATION NO/DATE: SWISSMEDIC 59389 06.12.2010 |
| 3141251 | SPC/GB20/075 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: A MEDICINAL PRODUCT CONSISTING OF A COMBINATION OF A FIRST DOSE PHARMACEUTICAL COMPOSITION AND A SECOND DOSE PHARMACEUTICAL COMPOSITION, THE FIRST DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS: POLYETHYLENE GLYCOL 3350, SODIUM SULPH; REGISTERED: IS IS/1/17/063/01 20171016; UK PL 20011/0040 20171016 |
| 0809498 | SPC/GB10/012 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 1224170 | SPC/GB15/018 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: NINTEDANIB*, THE TAUTOMERS AND THE SALTS THEREOF, IN PARTICULAR NINTEDANIB AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, SPECIFICALLY NINTEDANIB ESILATE. *NINTEDANIB IS 3-Z-(1-(4-N-((4-METHYL-PIPERAZIN-1-YL)-METHYLCARBONYL)-N-METHYL-AMINO)-A; REGISTERED: UK EU/1/14/954/001 20141125; UK EU/1/14/954/002 20141125; UK EU/1/14/954/003 20141125; UK EU/1/14/954/004 20141125 |
| 0788360 | SPC/GB04/021 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: BORTEZOMIB OR PHARMACEUTICALLY ACCEPTABLE ESTER THEREOF, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/274/001 20040428 |
| 1534313 | CA 2015 00072 | Denmark | ⤷ Subscribe | PRODUCT NAME: OKULAER SKYLLEVAESKE OMFATTENDE PHENYLEPHRIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER HYDROCHLORID OG KETOROLAC ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER KETOROLACTROMETAMOL; REG. NO/DATE: EU/1/15/1018 20150730 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
